Clinical Trials Logo
  1. Home
  2. Radiodermatitis
  3. NCT01263366

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

Radiodermatitis Clinical Trial

Official title:
Exploratory Study of Topical Norepinephrine in Post-Surgical Breast Cancer Patients Receiving Radiotherapy

Clinical Trial Summary

This study, a nonrandomized open-label Phase I safety and exploratory study, will evaluate the safety of topical norepinephrine in post-surgical breast cancer patients who are undergoing radiation therapy.

The study will also provide information about whether topical norepinephrine can prevent or decrease the severity of the radiation dermatitis experienced by these patients.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01263366
Study type Interventional
Source ProCertus BioPharm, Inc
Contact
Status Terminated
Phase Phase 1
Start date January 2011
Completion date April 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3
Withdrawn NCT04593914 - A Novel Skin Barrier Protectant for Acute Radiodermatitis N/A
Completed NCT06133218 - Patient Reported Outcomes Using Mepitel Film During Radiotherapy N/A
Enrolling by invitation NCT02289365 - Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients Phase 2
Completed NCT04483856 - Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis. N/A
Completed NCT02922244 - Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients N/A
Recruiting NCT05886673 - Development of a Protective Cream Against Radiodermatitis Caused by Radiotherapy. N/A
Withdrawn NCT01544504 - Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy Phase 1/Phase 2
Completed NCT03255980 - Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid® N/A
Not yet recruiting NCT03557983 - Evaluation of Fenofibrate on Radiation-induced Skin Injury N/A
Completed NCT02247830 - Management Radiodermatitis in Patients With Breast or Head and Neck Cancer Phase 3
Terminated NCT01367990 - Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy Phase 1
Completed NCT03924011 - Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy N/A
Not yet recruiting NCT04617730 - Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold. Phase 1/Phase 2
Not yet recruiting NCT05535452 - Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiotherapy N/A
Completed NCT04239560 - Preventive Effect of Boron-based Gel on Radiation Dermatitis Phase 3
Completed NCT02249884 - Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis Phase 2
Withdrawn NCT04692389 - Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis. N/A
Enrolling by invitation NCT04067310 - Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis. N/A
Enrolling by invitation NCT02251392 - Evaluation of Therapeutic Efficacy in Use of Chamomilla Gel, Chamomilla Infuse and Urea in Radiodermatitis Phase 3